Use of algorithms for identifying patients in a German claims database: learnings from a lung cancer case

Author:

Neugebauer Sina,Griesinger Frank,Dippel Sabine,Heidenreich Stephanie,Gruber Nina,Chruscz Detlef,Lempfert Sebastian,Kaskel Peter

Abstract

Abstract Background The analysis of statutory health insurance (SHI) data is a little-used approach for understanding treatment and care as well as resource use of lung cancer (LC) patients in Germany. The aims of this observational, retrospective, longitudinal analysis of structured data were to analyze the healthcare situation of LC patients in Germany based on routine data from SHI funds, to develop an algorithm that sheds light on LC types (non-small cell / NSCLC vs. small cell / SCLC), and to gain new knowledge to improve needs-based care. Methods Anonymized billing data of approximately four million people with SHI were analyzed regarding ICD-10 (German modification), documented medical interventions based on the outpatient SHI Uniform Assessment Standard Tariff (EBM) or the inpatient Operations and Procedure Code (OPS), and the dispensing of prescription drugs to outpatients (ATC classification). The study included patients who were members of 64 SHI funds between Jan-1st, 2015 and Dec-31st, 2016 and who received the initial diagnosis of LC in 2015 and 2016. Results The analysis shows that neither the cancer type nor the cancer stage can be unambiguously described by the ICD-10 coding. Furthermore, an assignment based on the prescribed medication provides only limited information: many of the drugs are either approved for both LC types or are used off-label, making it difficult to assign them to a specific LC type. Overall, 25% of the LC patients were unambiguously identifiable as NSCLC vs SCLC based on the ICD-10 code, the drug therapy, and the billing data. Conclusions The current coding system appears to be of limited suitability for drawing conclusions about LC and therefore the SHI patient population. This makes it difficult to analyze the healthcare data with the aim of gathering new knowledge to improve needs-based care. The approach chosen for this study did not allow for development of a LC differentiation algorithm based on the available healthcare data. However, a better overview of patient specific needs could make it possible to modify the range of services provided by the SHI funds. From this perspective, it makes sense, in a first step, to refine the ICD-10 system to facilitate NSCLC vs. SCLC classification.

Funder

MSD SHARP & DOHME, Haar, Germany

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Reference43 articles.

1. Robert-Koch-Institut and Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V., 2015. Krebs in Deutschland 2011/2012. 10th Edition. GEKID - Homepage. Available at: https://www.gekid.de. Accessed 05 Aug 2020. 

2. Griesinger F, Eberhardt W, Früh M, Gautschi O, et al. Lungenkarzinom, nicht-kleinzellig (NSCLC). [online] Onkopedia. 2019. Available at: https://www.onkopedia.com/de/onkopedia/guidelines/lungenkarzinom-nicht-kleinzellig-nsclc/@@guideline/html/index.html. Accessed 05 Aug 2020.

3. Wolf M, Eberhardt W, Früh M, Gautschi O, Griesinger F, Hilbe W, Hoffmann H, Huber RM, Loges S, Pirker R, Pöttgen C, Pritzkuleit R, Reck M, Reinmuth N, Sebastian M, Ukena D, Waller C, Wolf J, Wörmann B. Lungenkarzinom, kleinzellig (SCLC). [online] Onkopedia.  2019. Available at: https://www.onkopedia.com/de/onkopedia/guidelines/lungenkarzinom-kleinzellig-sclc/@@guideline/html/index.html. Accessed 05 Aug 2020.

4. Robert-Koch-Institut and Zentrum für Krebsregisterdaten. Krebs - Lungenkrebs. [online] Krebsdaten.de. 2016. Available at: https://www.krebsdaten.de/Krebs/DE/Content/Krebsarten/Lungenkrebs/lungenkrebs_node.html. Accessed 05 Aug2020.

5. Kraywinkel K, Schönfeld I. Epidemiologie des nichtkleinzelligen Lungenkarzinoms in Deutschland. Onkologe. 2018;24:946–51.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3